Sharemaestro Newsreel

GeneDx Holdings Corp. 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against GeneDx Holdings Corp. - WGS

Kahn Swick & Foti, LLC (KSF) is reminding investors in GeneDx Holdings Corp. (NasdaqGS: WGS) that they have until August 3, 2026, to apply for lead plaintiff in a securities class action lawsuit. The lawsuit alleges that GeneDx and its executives made false and …

VERACYTE, INC. 2026: Revenue $150.32M, EPS $0.31— 10-Q Summary

Veracyte (VCYT) reported its second-quarter 2026 results, showing significant growth with revenue reaching $150.32M and diluted EPS of $0.31. This represents a 15.5% year-over-year increase in revenue and a substantial turnaround from a net loss in the previous year, driven by strong testing revenue …

Guardant Health (GH) Stock Jumps As Shield Growth Masks Loss Pressure

Guardant Health (GH) stock increased by 6.3% despite widening losses, as Q2 revenue grew 44% to US$335 million, driven significantly by Shield testing, which saw a more than threefold increase in revenue and test volumes. The market is focusing on the growth story and …

Form 144 Castle Biosciences For: 1 August By Investing.com

This article announces the filing of Form 144 for Castle Biosciences (CSTL) on August 1st. It provides a brief mention of the company's stock performance, showing a 4.52% increase. The content largely consists of market data, trending stocks, and various financial tools provided by …

Myriad Genetics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:MYGN) 2026-08-01

Myriad Genetics, Inc. (MYGN) released its Q2 2026 earnings call presentation, detailing financial results. The company reported an EPS of -$0.25, missing estimates by $0.19, and revenue of $190.70M, which was down 10.51% year-over-year and missed estimates by $15.33M. This article provides access to …

Precipio Inc (PRPO) Financial Health: Profitability & Balance Sheet Analysis

Precipio Inc (PRPO) has a weak financial status with a score of 4.51, ranking 199 out of 200 in its industry. Despite this, the company reported a significant year-over-year revenue increase of 36.15% and a net profit increase of 63.24% in its latest quarter. …

Qiagen NV (QGEN.BRN) Q4 2024 Earnings Report - Results, Call & Slides

Qiagen NV (QGEN.BRN) reported its Q4 2024 earnings, missing the consensus EPS estimate by -CHF0.01 with an actual EPS of CHF0.52. However, the company beat revenue expectations, reporting CHF424.78M against an expected CHF424.66M, marking a 2.36% year-over-year revenue growth. The earnings call and slide …

CareDx (CDNA) Stock Jumps As Profitability Recasts The Growth Story

Precipio (NASDAQ: PRPO) plans Q2 2026 shareholder call with live Q&A

Precipio, Inc. (NASDAQ: PRPO) announced it will host a Q2-2026 shareholder update call on August 17, 2026, at 5:00 PM ET. The call will cover updates on the company's core businesses and include a live moderated Q&A session. CEO Ilan Danieli expressed optimism about …

Fulgent Genetics (NASDAQ:FLGT) Announces Quarterly Earnings Results

Fulgent Genetics (NASDAQ:FLGT) reported disappointing quarterly earnings, missing analyst estimates for both EPS and revenue due to revenue-cycle issues, including delayed billing and lower collection rates. The company also reduced its full-year 2026 guidance, forecasting lower revenue and negative non-GAAP EPS. Despite these setbacks, …

Iqvia EVP, general counsel Eric Sherbet sells $1.25m in stock

Eric Sherbet, EVP and General Counsel at IQVIA Holdings Inc. (NYSE:IQV), sold 5,000 shares of company stock for $1.25 million on July 29, 2026. This transaction occurred as IQVIA's stock trades near its 52-week high, following a significant 13% return in the prior week. …

NEUP|Neuphoria Therapeutics Inc|Price:3.880|Chg%:-0.040

This article provides a comprehensive stock analysis of Neuphoria Therapeutics Inc (NEUP) from TradingKey. It highlights the company's strong fundamentals and high growth potential, despite its stock trading sideways between support and resistance levels. The analysis also covers its valuation, institutional ownership, analyst ratings, …

Enterprise value to EBITDA forward of Natera, Inc. – NASDAQ:NTRA

This article provides a financial metric, the Enterprise Value to EBITDA forward, for Natera, Inc. (NASDAQ: NTRA). It appears to be a financial data snippet from TradingView, focusing on Natera's financial overview. The content is primarily a data point without further analysis or discussion.

Enterprise value to EBITDA forward of IDEXX Laboratories, Inc. – NASDAQ:IDXX

The article provides the Enterprise Value to EBITDA forward for IDEXX Laboratories, Inc. (NASDAQ: IDXX). It indicates that the market was closed at the time of data retrieval and that there were no trades. The content primarily focuses on financial data availability for the …

Precipio Inc. Q2 Results: Shareholder update call set for August 17

Precipio Inc. has scheduled its Q2-2026 shareholder update call for August 17, 2026, at 5:00 PM ET. CEO Ilan Danieli will discuss core business updates and progress in customer acquisition and pipeline expansion. Investors can participate in a live Q&A session or submit questions …

Castle Biosciences (CSTL) Stock Climbs On Higher Sales Outlook Despite Margin Pressure

Castle Biosciences (CSTL) stock saw a 4.5% jump after its Q2 earnings report, driven by a 20% revenue increase to US$103.5m and an uplifted full-year sales guidance, despite reporting a small net loss. The market appears to be prioritizing the strong top-line growth and …

IQVIA SVP Keriann Cherofsky sells $136,827 in company stock

Keriann Cherofsky, SVP and Corporate Controller at IQVIA Holdings Inc. (NASDAQ:IQV), sold 558 shares of company stock for a total of $136,827 on July 29, 2026. This transaction occurred while the stock was trading near its 52-week high after a significant gain. Following the …

Baird Maintains Icon PLC(ICLR.US) With Buy Rating, Raises Target Price to $194

Baird has reiterated its Buy rating on Icon PLC (ICLR.US) and increased its price target to $194. This suggests a positive outlook from the analyst firm regarding the company's future performance and stock value.

DGX|Quest Diagnostics Inc|Price:233.010|Chg%:-1.190

This article provides an overview of Quest Diagnostics Inc. (DGX), detailing its current stock performance, key financial figures, and analyst ratings. The company is highlighted for its healthy fundamentals, high growth potential, and strong institutional ownership, with analysts generally rating it as a "Buy" …

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CareDx, Inc. (Nasdaq: CDNA) has announced inducement grants of 15,822 restricted stock units (RSUs) to James McNally, their newly appointed Executive Advisor. These RSUs were granted under the Company's 2025 Inducement Equity Incentive Plan, in accordance with Nasdaq Listing Rule 5635(c)(4). The grants are …

Labcorp (LH) Launches Marker Genetic Health Panel For Consumer Testing

Labcorp (LH) has introduced the Marker by Labcorp Genetic Health Panel, a new consumer-focused genetic testing service that combines genetic testing, counseling, and biomarker analysis. This launch integrates Labcorp's existing infrastructure with new AI-powered platforms to provide tailored health insights. The company's stock has …

Labcorp (LH) Stock Holds A Bullish Case On Margin Expansion

Labcorp (LH) reported strong Q2 2026 earnings with increased revenue and basic EPS, and significant margin expansion, with net margin rising to 7% from 5.7% a year prior. Management also raised its full-year revenue and adjusted EPS guidance, indicating a steady bullish trend despite …

DTIL|Precision BioSciences Inc|Price:6.990|Chg%:-0.010

This article provides a comprehensive stock analysis of Precision BioSciences Inc (DTIL), highlighting its strong fundamentals, high growth potential, and "Strong Buy" analyst rating. Despite recent weak stock market performance, the company is developing gene editing therapies using its proprietary ARCUS platform and is …

Thermo Fisher Scientific Inc Revenue Breakdown – NYSE:TMO

Revvity declares $0.07 quarterly dividend per share

Revvity, Inc. (NYSE:RVTY) has announced a quarterly dividend of $0.07 per share of common stock. This dividend will be paid on November 13, 2026, to shareholders on record by October 23, 2026. Revvity is a health science solutions company with 2025 revenue of $2.9 …

Iqvia CEO Ari Bousbib sells $26.1m in company stock

IQVIA Holdings Inc. CEO Ari Bousbib sold approximately $26.09 million worth of company stock on July 29, 2026, after acquiring shares through the exercise of stock appreciation rights. Despite the sale, Bousbib still directly and indirectly holds a significant number of shares. This comes …

IQVIA Holdings Inc. (NYSE: IQV) SVP reports sale of 558 common shares

Keriann Cherofsky, SVP and Corporate Controller of IQVIA Holdings Inc. (NYSE: IQV), sold 558 common shares at $245.21 per share on July 29, 2026. Following this transaction, she directly holds 2,989 shares of the company. The sale was an open market or private transaction …

Iqvia Holdings Insider Sold Shares Worth $1,245,800, According to a Recent SEC Filing

An insider at Iqvia Holdings sold shares valued at $1,245,800, as disclosed in a recent SEC filing. The article also mentions recent analyst rating adjustments for IQVIA Holdings, with several firms raising their price targets while maintaining favorable ratings. Iqvia Holdings is a leading …

Mettler-Toledo International Inc. stock outperforms competitors on strong trading day

Shares of Mettler-Toledo International Inc. (MTD) rose 2.59% to $1,416.30 on Friday, outperforming both the S&P 500 Index and the Dow Jones Industrial Average. This increase ended a two-day losing streak for the company's stock. The positive movement occurred on a strong trading day …

Trading the Move, Not the Narrative: (NTRA) Edition

This article provides an AI-generated analysis of Natera Inc. (NASDAQ: NTRA), highlighting weak near and mid-term sentiment but a strong long-term outlook. It details three trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels, and emphasizes an exceptional risk-reward short …

Revvity Keeps Quarterly Dividend at $0.07 a Share, Payable Nov. 13 to Holders of Record Oct. 23

Revvity, Inc. has announced that it will maintain its quarterly dividend at $0.07 per share. The dividend is scheduled to be paid on November 13 to shareholders who are on record as of October 23.

AGEN|Agenus Inc|Price:7.500|Chg%:-0.410

TradingKey provides a comprehensive stock analysis for Agenus Inc (AGEN), highlighting its stable fundamentals, high growth potential, and "fairly valued" status within the Biotechnology & Medical Research industry. The analysis notes high institutional ownership and recent "Buy" ratings from analysts with a target price …

Bellanova (BLLN) holder Shan Sakakibara files to sell 4,000 Class A shares

Shan Sakakibara, a holder of Bellanova (BLLN) Class A shares, has filed a Form 144 to sell 4,000 shares with an aggregate market value of $560,840.00. The filing also discloses previous sales by Sakakibara in June and July 2026, totaling 24,000 Class A shares …

ALMS|Alumis Inc|Price:26.970|Chg%:-1.280

This article provides a comprehensive stock analysis of Alumis Inc (ALMS), highlighting its relatively healthy fundamentals, significant growth potential, and "Strong Buy" analyst rating with a high price target. It details the company's biopharmaceutical focus, including its pipeline of therapies for immune-mediated and neuroinflammatory …

ICON plc Stock 12‑Month Price Target Raised to $187.6, Implies 13% Upside

Analysts have raised the average 12-month price target for ICON plc stock (ICLR) to $187.6, up from $186.6, with individual forecasts ranging from $160 to $220. This new target suggests a 13% potential upside based on the Jul. 30 closing price. The consensus rating …

IQVIA Holdings (NYSE: IQV) insider plans stock sale via Morgan Stanley

An insider at IQVIA Holdings Inc. (IQV) has filed a Form 144, indicating a proposed sale of common stock through Morgan Stanley Smith Barney LLC’s Executive Financial Services unit. The filing details various underlying equity awards, including performance shares and restricted stock granted between …